Aspirin resistance - Does it clinically matter?

Clinical Research in Cardiology

Volumn 95, Issue 10, 2006, Pages 505-510

  Schrör, Karsten ^a   Hohlfeld, T ^a   Weber, A A ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

"Aspirin resistance"; Coronary prevention; Platelet function; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; THROMBOXANE;

ASPIRIN RESISTANCE; CORONARY ARTERY DISEASE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SENSITIVITY; EX VIVO STUDY; GRAFT OCCLUSION; HEART PROTECTION; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOSIS PREVENTION; TREATMENT FAILURE;

ASPIRIN; BLOOD PLATELETS; DRUG RESISTANCE; HUMANS; PLATELET AGGREGATION INHIBITORS; TREATMENT FAILURE;

EID: 33749331806     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-0424-5     Document Type: Review

References (38)

1. Mukherjee D, Topol EJ (2002) Pharmacogenomics in cardiovascular diseases. Progr Cardiovasc Dis 44:479-498
2. Cattaneo M (2004) Aspirin and clopidogrel. Efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol 24:1980-1987
3. McKee SA, Sane DC, Deliargyris EN (2002) Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thromb Haemost 88:711-715
4. Sztriha LK, Sas K, Vecsei L (2005) Aspirin resistance in stroke: 2004. J Neurol Sci 229/230:163-169
5. Mason PJ, Jacobs AK, Freedman JE (2005) Aspirin resistance and atherothrombotic disease. J Am Coll Cardiol 46:986-993
6. Hennekens CH, Schrör K, Weisman S, FitzGerald GA (2004) Terms and Conditions. Semantic complexicity and aspirin resistance. Circulation 110:1706-1708
7. Sanderson S, Emery J, Baglin T, Kinmonth AL (2005) Narrative review: aspirin resistance and its clinical implications. Ann Intern Med 142:370-380
8. Vejar M, Fragasso G, Hackett D et al (1990) Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb Haemost 63:163-168
9. Benedek ICH, Joshi AS, Pieniaszek HJ, King S-YP, Kornhauser DM (1995) Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol 35:1181-1186
10. Buchanan MR, Brister SJ (1995) Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 11:221-227
11. Lee PY, Chen WH, Ng W et al (2005) Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 118:723-727
12. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 324:71-86
13. Schrör K (1997) Aspirin and platelets: The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Sem Thromb Hemost 23:349-356
14. Reilly IAG, FitzGerald GA (1987) Inhibition of thromboxane formation in vivo and ex vivo. Blood 69:180-186
15. 2 for their receptor are similar in washed human platelets. Biochem Biophys Acta 157:733-739
16. Weber AA, Przytulski B, Schanz A, Hohlfeld T, Schrör K (2002) Towards a definition of aspirin resistance: a typological approach. Platelets 13:37-40
17. Catella-Lawson F, Reilly MP, Kapoor SC et al (2001) Cyclooxygenase inhibitors and the antiplatelet effect of aspirin. N Engl J Med 345:1809-1817
18. Cambria-Kiely JA, Gandhi PJ (2002) Aspirin resistance and genetic polymorphism. J Thromb Thrombolysis 14:51-58
19. Halushka MK, Walker MP, Halushka PV (2003) Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther 73:122-130
20. Weber AA, Zimmermann KC, Meyer-Kirchrath J, Schrör K (1999) Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance. Lancet 353:900
21. Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, Schrör K, Hohlfeld T (2003) Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 108:542-547
22. Censarek P, Freidel K, Udelhoven M et al (2004) Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting. Thromb Haemost 92:925-928
23. Audoly LP, Rocca B, Fabre JE et al (2000) Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation 101:2833-2840
24. Cipollone F, Ciabattoni G, Patrignani P et al (2000) Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 102:1007-1013
25. Kawasaki T, Ozeki Y, Igawa T, Kambayashi J (2000) Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke 31:591-595
26. Lim E, Ali Z, Ali A, Routlege T, Edmonds L, Altman DG, Large S (2003) Indirect comparison meta-analysis of aspirin therapy after coronary surgery. Br Med J 327:1309-1314
27. 2 and prostacyclin. Stroke 23:1400-1403
28. Helgason CM, Bolin KM, Hoff JA et al (1994) Development of aspirin resistance in persons with previous ischemic stroke. Stroke 25:2331-2336
29. Mueller MR, Salat A, Stangl P et al (1997) Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 78:1003-1007
30. De Gaetano G, Cerletti C (2003) Aspirin resistance: a revival of platelet aggregation tests? J Thromb Haemost 1:2048-2061
31. Bhatt DL, Topol EJ (2003) Scientific and therapeutic advances in antiplatelet therapy. Nature Rev Drug Discov 2:15-28
32. Gum PA, Kottke-Marchant K, Poggio ED et al (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88:230-235
33. 2 formation in the human circulation. Proc Natl Acad Sci (USA) 83:5861-5865
34. Montalescot G, Maclouf J, Drobinski G et al (1994) Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin. J Am Coll Cardiol 24:33-38
35. Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105:1650-1655
36. Chen WH, Lee PY, Ng W, Tse HF, Lau CP (2004) Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43:1122-1126
37. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41:961-965
38. Wang JC, Aucoin-Barry D, Manuelian D et al (2003) Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA. Am J Cardiol 92:1492-1494